       Document 0290
 DOCN  M9620290
 TI    Critical neurologic illness in the immunocompromised patient.
 DT    9602
 AU    Cohen JA; Raps EC; Mellon Center for Multiple Sclerosis, Cleveland,
       Ohio, USA.
 SO    Neurol Clin. 1995 Aug;13(3):659-77. Unique Identifier : AIDSLINE
       MED/96015342
 AB    Immunocompromised patients are vulnerable to a host of neurologic
       problems that may complicate their clinical course and necessitate
       intensive care. Atypical and opportunistic infections represent the
       primary concern in such patients and can cause a variety of neurologic
       complications. In addition, these patients are susceptible to neurologic
       dysfunction induced by drugs or underlying disease states. This article
       emphasizes the diagnostic approach to selected clinical syndromes in the
       immunocompromised patient, such as encephalopathy, seizures, and stroke.
 DE    Acquired Immunodeficiency Syndrome  Anti-Inflammatory Agents,
       Steroidal/ADMINISTRATION & DOSAGE/  ADVERSE EFFECTS/THERAPEUTIC USE
       Antibody Formation  Azathioprine/ADMINISTRATION & DOSAGE/ADVERSE
       EFFECTS/THERAPEUTIC  USE  Brain Diseases/*ETIOLOGY/PHYSIOPATHOLOGY  Case
       Report  Confusion/CHEMICALLY INDUCED/PHYSIOPATHOLOGY
       Cyclosporine/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/THERAPEUTIC  USE
       Graft Rejection/DRUG THERAPY  Human  Immunologic
       Diseases/*COMPLICATIONS/ETIOLOGY  Immunosuppressive
       Agents/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/  THERAPEUTIC USE  Kidney
       Transplantation/*ADVERSE EFFECTS  Male  Middle Age
       Prednisone/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/THERAPEUTIC  USE
       JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

